| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO And Treasurer
2 companies
Krognes Steve E. is a Director at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,377 | $30.88 | $42,521.76 | -0.9% | -10.4% | -43.6% | |
| Jan 5, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,970 | $28.44 | $84,466.80 | -2.0% | -16.1% | -32.7% | |
| Aug 19, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,253 | $33.22 | $74,844.66 | -1.5% | -12.6% | -31.9% | |
| Feb 11, 2022 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 2,560 | $34.69 | $88,806.40 | -2.1% | -37.4% | -16.4% | |
| Feb 9, 2022 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 1,296 | $37.09 | $48,072.66 | -1.0% | -40.1% | -21.7% | |
| Jan 5, 2022 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 2,225 | $44.75 | $99,568.75 | -1.8% | -25.3% | -35.5% | |
| Aug 19, 2021 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 2,285 | $49.57 | $113,263.20 | -1.2% | +1.5% | -31.6% | |
| Mar 15, 2021 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 50,000 | $61.89 | $3,094,563.14 | -1.4% | +21.0% | -52.2% | |
| Feb 16, 2021 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 50,000 | $65.09 | $3,254,710.05 | -1.4% | - | - | |
| Feb 11, 2021 | DNLI Denali Therapeutics Inc. | CFO And Treasurer | Sell | 3,035 | $70.34 | $213,479.69 | -1.5% | - | - |